Cologne – With immediate effect Dr. Florian Dannheim is the Chief Financial Officer at pfm medical ag. He is, thus, the successor to Reinhard Blunck, who retired at the beginning of January 2016. In his role the doctor of business engineering is taking over the controlling of the business development for the internationally operating medical technology company.
Dannheim has gained a lot of experience, both within Germany and abroad, in the development and implementation of finance strategies across corporate group structures. Different positions in the field of consultancy and within companies following his studies prepared him for his area of responsibility at pfm medical ag: In 1999 he began his career as a consultant with Boston Consulting Group. His first position on the company side was in 2002 at Hilti AG, where he finally became responsible for developing the business in the United Kingdom as Financial Director. In 2006 he transferred from the construction industry to the steel industry, to Klöckner & Co., where he worked as the Manager of Corporate Controlling, M&A and Corporate Development. He completed his business engineering studies at the Technical University in Darmstadt, where he also completed his doctorate thesis.
“With Dr. Dannheim we are pleased to have gained a board colleague who combines technological understanding with comprehensive knowledge of key corporate figures in one person,” says Aurel Schoeller, Chairman of the Board at pfm medical ag. “The board is now complete again and very well prepared for the implementation of our growth strategy in the next years.” Dannheim completes the board team, which apart from Aurel Schoeller as the chairman also includes Andreas Gottschalk as COCM (Chief Officer Customer and Markets).
------------------------
Short profile
pfm medical is a leading German company in the medical technology sector. The Cologne family enterprise, founded in 1971, is represented worldwide with more than 500 employees at 12 locations. In 2014, pfm medical generated revenues of 95.4 million euros and a profit before interest and taxes (EBIT) of 9.6 million euros. With 3,100 products distributed in over 100 markets, as well as various medical services, pfm medical provides a broad portfolio of products and services. The offering covers in the medical application fields include infusion, histotechnology, cardiovascular technologies and surgery. Whether for products or services – apart from flawless functioning, pfm medical focuses on the patient's quality of life above all.
Contact
pfm medical ag Ute Ebers Head of Corporate Communications Wankelstraße 60 50996 Köln T +49 (0)2236 9641-370 F +49 (0)2236 9641-99-370 ute.ebers[at]pfmmedical[dot]com
↧